FDA Inspection
Amneal Pharmaceuticals Private Ltd.Amneal Pharmaceuticals Private Ltd. – FDA Inspection, Apr 24, 2018
Record Details
This FDA Inspection record concerns Amneal Pharmaceuticals Private Ltd., with an inspection on April 24, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Marie B. Buen-Bigornia (Issuing Officer)
- Niketa Patel (FDA Associated Person)
View Company Profile
ID · c1c002a3-f074-4613-84ec-405ee6de67f2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1052362
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Amneal Pharmaceuticals Private Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 23, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amneal Pharmaceuticals Private Ltd.
- FDA Inspection 1242127 - 2024-06-19
- FDA Inspection 1200654 - 2022-12-23
- FDA Inspection 1120398 - 2020-02-18
- FDA Inspection 1085771 - 2019-04-05
- FDA Inspection 1015639 - 2017-03-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.